Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
US8088779B2 · kind B2 · utility
1Cited by
5References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 28, 2006 |
| Grant date | Jan 3, 2012 |
| Priority date | — |
| Expiry date | Sep 28, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to the polymorph Form 2 of [3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-[(S)-1-(3-methyl-[1,2,4]oxa-diazol-5-yl)-propyl]amine. The present invention also relates to pharmaceutical compositions comprising the same and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.